Yuting He

2.2k total citations
65 papers, 1.2k citations indexed

About

Yuting He is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Yuting He has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 36 papers in Cancer Research and 10 papers in Epidemiology. Recurrent topics in Yuting He's work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (22 papers) and Circular RNAs in diseases (14 papers). Yuting He is often cited by papers focused on Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (22 papers) and Circular RNAs in diseases (14 papers). Yuting He collaborates with scholars based in China, United States and United Kingdom. Yuting He's co-authors include Wenzhi Guo, Qiyao Zhang, Qingyuan Zheng, Xiao Yu, Juan Li, Jie Li, Shuijun Zhang, Xiaorui Liu, Xiao Yu and Ranran Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hazardous Materials.

In The Last Decade

Yuting He

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting He China 21 904 624 180 154 94 65 1.2k
Gui Hu China 20 758 0.8× 599 1.0× 127 0.7× 119 0.8× 104 1.1× 48 1.1k
Hao Zhuang China 21 770 0.9× 460 0.7× 118 0.7× 180 1.2× 57 0.6× 60 1.1k
Jianyong Sun China 19 1.1k 1.2× 733 1.2× 90 0.5× 118 0.8× 107 1.1× 45 1.4k
Jiangfeng Li China 22 1.1k 1.2× 717 1.1× 171 0.9× 158 1.0× 103 1.1× 48 1.4k
Nan Zhao China 24 959 1.1× 672 1.1× 125 0.7× 284 1.8× 49 0.5× 49 1.3k
Yun Zhu China 22 680 0.8× 336 0.5× 113 0.6× 182 1.2× 86 0.9× 43 1.1k
Chengfei Jiang China 21 880 1.0× 707 1.1× 97 0.5× 168 1.1× 71 0.8× 46 1.2k

Countries citing papers authored by Yuting He

Since Specialization
Citations

This map shows the geographic impact of Yuting He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting He more than expected).

Fields of papers citing papers by Yuting He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting He. The network helps show where Yuting He may publish in the future.

Co-authorship network of co-authors of Yuting He

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting He. A scholar is included among the top collaborators of Yuting He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting He. Yuting He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiao, Yuting He, Yongjie Xue, et al.. (2025). In-situ passivation of Cr/Cr (VI) in the co-combustion ash of dyeing sludge and biomass via controlling the phase transformation of sulfate. Journal of Hazardous Materials. 492. 138137–138137. 2 indexed citations
2.
He, Danni, Rui Sun, Jiaqi Zhou, et al.. (2025). CNV-mediated dysregulation of the ceRNA network mechanism revealed heterogeneity in diffuse and intestinal gastric cancers. Journal of Translational Medicine. 23(1). 308–308.
3.
He, Yuting, et al.. (2024). Experimental study on the effect of CO2 dynamic sequestration on sandstone pore structure and physical properties. Fuel. 375. 132622–132622. 6 indexed citations
4.
Zhao, Xin, et al.. (2024). Sappanone A ameliorates acute lung injury through inhibiting the activation of the NF-κB signaling pathway. Toxicology and Applied Pharmacology. 492. 117127–117127. 3 indexed citations
5.
6.
Guo, Ran, et al.. (2024). Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Journal of Inflammation Research. Volume 17. 9757–9771.
7.
Chen, Di, Lixia Xu, Weitao Shen, et al.. (2024). Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. SHILAP Revista de lepidopterología. 3(5). e238–e238. 23 indexed citations
8.
Zhang, Shuijun, et al.. (2024). Novel molecular hepatocellular carcinoma subtypes and RiskScore utilizing apoptosis-related genes. Scientific Reports. 14(1). 3913–3913.
9.
Gu, Xinyu, et al.. (2023). Polyamines: their significance for maintaining health and contributing to diseases. Cell Communication and Signaling. 21(1). 348–348. 50 indexed citations
10.
He, Yuting, et al.. (2023). Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. Journal of Translational Medicine. 21(1). 68–68. 41 indexed citations
11.
Xiong, Fei, et al.. (2022). Crucial Roles of miR-625 in Human Cancer. Frontiers in Medicine. 9. 845094–845094. 9 indexed citations
12.
Yu, Xiao, et al.. (2022). MIR4435-2HG: A newly proposed lncRNA in human cancer. Biomedicine & Pharmacotherapy. 150. 112971–112971. 19 indexed citations
13.
Li, Mingxing, Xiao Yu, Qingyuan Zheng, et al.. (2021). Promising role of long non-coding RNA PCAT6 in malignancies. Biomedicine & Pharmacotherapy. 137. 111402–111402. 10 indexed citations
14.
Xu, Yating, Xiao Yu, Qingyuan Zheng, et al.. (2021). Promising Advances in LINC01116 Related to Cancer. Frontiers in Cell and Developmental Biology. 9. 736927–736927. 22 indexed citations
15.
He, Yuting, et al.. (2021). The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion. Investigational New Drugs. 39(3). 713–723. 12 indexed citations
16.
Zheng, Qingyuan, et al.. (2021). Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors. Frontiers in Cell and Developmental Biology. 9. 750084–750084. 7 indexed citations
17.
Yu, Xiao, et al.. (2020). A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes. Frontiers in Oncology. 10. 560229–560229. 6 indexed citations
18.
He, Yuting, Qing Yang, Yuqi Zhu, et al.. (2019). Efficient Generation of an Fah/Rag2 Dual-Gene Knockout Porcine Cell Line Using CRISPR/Cas9 and Adenovirus. DNA and Cell Biology. 38(4). 314–321. 5 indexed citations
19.
Liu, Xiaorui, et al.. (2019). MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1. Cancer Cell International. 19(1). 15–15. 78 indexed citations
20.
Bao, Jie, Yan Yu, Jianan Chen, et al.. (2018). MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death and Disease. 9(10). 1045–1045. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gui Hu Breakdown of academic impact, for papers by Hao Zhuang Breakdown of academic impact, for papers by Jianyong Sun Breakdown of academic impact, for papers by Jiangfeng Li Breakdown of academic impact, for papers by Nan Zhao Breakdown of academic impact, for papers by Yun Zhu Breakdown of academic impact, for papers by Chengfei Jiang
Rankless by CCL
2026